Intelligence / Healthtech / New Clinical Trials / CareDx
Clinicaltrial registered10 Nov 2026
CareDx
10 Nov 2026: Trial registered · HistoMap AlloSure Renal Biopsies Observational Research Study. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 10 Nov 2026
- Title
- HistoMap AlloSure Renal Biopsies Observational Research Study
- Conditions
- Kidney Transplant Rejection, T-Cell Mediated Rejection, Kidney Transplantation, Antibody Mediated Rejection
- Study Type
- Observational
- Status
- Not Yet Recruiting
- Reference
- NCT07927374
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at CareDx
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for CareDx in our registers.
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.